BioCentury | Sep 19, 2016
Company News
Basilea, Grupo Biotoscana deal
...Basilea granted Grupo Biotoscana exclusive rights to commercialize Cresemba isavuconazole and Zevtera ceftobiprole in 19 Latin American...
...aureus (MRSA). The companies declined to disclose additional details. Basilea Pharmaceutica Ltd. (SIX:BSLN), Basel, Switzerland Grupo Biotoscana S.L....
...aureus (MRSA). The companies declined to disclose additional details. Basilea Pharmaceutica Ltd. (SIX:BSLN), Basel, Switzerland Grupo Biotoscana S.L....
